pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
TARGET
save

BTK

Bruton's tyrosine kinase; B-cell malignancy and autoimmune target.

also known as: brutons tyrosine kinase

🐶 often sniffed alongside

top 7
  • tagAdCom7 co-mentions · 6 sources
  • tagPMA Approval7 co-mentions · 6 sources
  • drugeverolimus SR5 co-mentions · 5 sources
  • drugEVEROLIMUS5 co-mentions · 5 sources
  • drugeverolimus ODT5 co-mentions · 5 sources
  • drugZortress5 co-mentions · 5 sources
  • tagRecall1 co-mentions · 1 sources
drugs
0
catalysts
0
news
190
companies
0

Top drugs

no drugs tagged with this interest yet

🐶 Top companies

no companies tagged with this interest yet

Recent catalysts

no catalysts tagged with this interest yet

Recent news

view all →
  • Merck scraps centerpiece of $2.7B ArQule buy after late-stage safety concerns↗
    biospace · 3d ago
  • STAT+: Pharmalittle: We’re reading about Overton FDA nomination being yanked, a Merck setback, and more↗
    stat · 3d ago
  • Merck ends the sorry saga of BTK inhibitor it got from ArQule↗
    endpoints · 4d ago
  • 5 acquisitions that forced Big Pharmas to co-parent↗
    biospace · 4d ago
  • Merck axes $2.7B BTK inhibitor program after seeing phase 3 data↗
    fiercebiotech · 4d ago
  • China has a clear shot to 2030 goals, though economic, cultural barriers remain↗
    biospace · 11d ago
  • Could we see 10 Chinese Big Pharmas within a decade? Some CEOs think so↗
    fiercebiotech · 15d ago
  • Sanofi’s axing of Nurix STAT6 program ‘not a target-related issue’↗
    biospace · 17d ago
Data sources
openFDA · ClinicalTrials.gov · pharmadog Linker
last refreshed 5h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?